Total Payments
$3,305
2024 Payments
$718.78
Companies
16
Transactions
253
Medicare Patients
2,820
Medicare Billing
$227,936
Payment Breakdown by Category
Food & Beverage$3,148 (95.2%)
Education$157.06 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,148 | 249 | 95.2% |
| Education | $157.06 | 4 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,987 | 156 | $0 (2024) |
| Allergan, Inc. | $698.60 | 63 | $0 (2022) |
| Biogen, Inc. | $188.12 | 6 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $80.85 | 5 | $0 (2024) |
| Lilly USA, LLC | $68.62 | 5 | $0 (2023) |
| PFIZER INC. | $66.89 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $44.23 | 3 | $0 (2020) |
| EMD Serono, Inc. | $28.84 | 2 | $0 (2019) |
| GE HEALTHCARE | $28.54 | 2 | $0 (2018) |
| Biohaven Pharmaceutical Holding Company Ltd. | $24.85 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $718.78 | 73 | ABBVIE INC. ($594.19) |
| 2023 | $933.21 | 59 | ABBVIE INC. ($700.47) |
| 2022 | $769.54 | 46 | ABBVIE INC. ($620.12) |
| 2021 | $446.61 | 41 | Allergan, Inc. ($359.71) |
| 2020 | $340.61 | 27 | Allergan, Inc. ($282.54) |
| 2019 | $67.57 | 5 | EMD Serono, Inc. ($28.84) |
| 2018 | $28.54 | 2 | GE HEALTHCARE ($28.54) |
All Payment Transactions
253 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/06/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/02/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/19/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Neurology | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/25/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/23/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Neurology | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.59 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.82 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.83 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/27/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.97 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $7.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/30/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $8.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.45 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 588 | 841 | $181,222 | $50,204 |
| 2022 | 12 | 671 | 962 | $151,770 | $61,608 |
| 2021 | 13 | 727 | 1,019 | $164,995 | $63,503 |
| 2020 | 13 | 834 | 1,042 | $143,896 | $52,621 |
Total Patients
2,820
Total Services
3,864
Medicare Billing
$227,936
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 260 | 459 | $87,511 | $30,337 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 46 | 46 | $14,610 | $4,221 | 28.9% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 74 | 74 | $27,010 | $3,174 | 11.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 22 | 26 | $8,195 | $2,303 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 44 | 50 | $5,020 | $2,290 | 45.6% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 25 | 25 | $10,200 | $2,013 | 19.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 37 | 54 | $8,478 | $1,883 | 22.2% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 15 | 15 | $6,270 | $1,506 | 24.0% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 19 | 19 | $5,168 | $1,140 | 22.1% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 35 | 62 | $4,030 | $861.80 | 21.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 11 | 11 | $4,730 | $475.97 | 10.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 269 | 487 | $64,150 | $33,338 | 52.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 67 | 67 | $11,390 | $6,700 | 58.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 39 | $7,215 | $4,219 | 58.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 66 | 66 | $24,090 | $2,848 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 54 | 60 | $5,830 | $2,806 | 48.1% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 23 | 23 | $7,038 | $2,400 | 34.1% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 30 | 30 | $7,380 | $2,388 | 32.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 47 | 67 | $7,638 | $2,347 | 30.7% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 22 | 24 | $4,464 | $1,511 | 33.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 11 | 11 | $2,475 | $1,422 | 57.5% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 42 | 76 | $4,940 | $1,089 | 22.0% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 12 | 12 | $5,160 | $539.98 | 10.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 275 | 488 | $62,730 | $34,100 | 54.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 66 | 66 | $11,490 | $6,400 | 55.7% |
About Dr. Robert Margolis, M.D
Dr. Robert Margolis, M.D is a Neurology healthcare provider based in Bridgeton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497732812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Margolis, M.D has received a total of $3,305 in payments from pharmaceutical and medical device companies, with $718.78 received in 2024. These payments were reported across 253 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($3,148).
As a Medicare-enrolled provider, Margolis has provided services to 2,820 Medicare beneficiaries, totaling 3,864 services with total Medicare billing of $227,936. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Bridgeton, MO
- Active Since 12/28/2005
- Last Updated 11/05/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1497732812
Products in Payments
- BOTOX (Biological) $1,861
- QULIPTA (Drug) $498.58
- UBRELVY (Drug) $325.56
- EMGALITY (Drug) $68.62
- TECFIDERA (Drug) $67.30
- ZEPOSIA (Drug) $62.82
- Tysabri (Biological) $60.00
- KESIMPTA (Drug) $40.04
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $35.36
- TYSABRI (Biological) $31.14
- VUMERITY (Drug) $29.68
- Mavenclad (Biological) $28.84
- GILENYA (Drug) $27.87
- NURTEC ODT (Drug) $24.85
- Rystiggo (Drug) $16.87
- COMIRNATY (Biological) $15.77
- PANZYGA (Biological) $15.76
- APOKYN (Drug) $13.84
- ACTIVA PC (Device) $13.48
- MAYZENT (Drug) $12.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bridgeton
Dr. Siddharth Kaul, Md, MD
Neurology — Payments: $552,004
Neurology $552,004
Dr. Daniel Mattson, Md, MD
Neurology — Payments: $500,463
Neurology $500,463
Dr. Seth Hepner, Md, MD
Neurology — Payments: $251,257
Neurology $251,257
Dr. Xinrong Lu, M.d, M.D
Neurology — Payments: $22,610
Neurology $22,610
Dr. Amer Alshekhlee, Md, MD
Neurology — Payments: $14,239
Neurology $14,239
Dr. Chizoba Ezepue, Md, MD
Neurology — Payments: $5,505
Neurology $5,505